RecruitingNot ApplicableNCT02678884

Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study

A Pilot Study of 18F-FDG PET-CT Kinetic Analysis in Head and Neck Squamous Cell Carcinoma (HNSCC)


Sponsor

University Health Network, Toronto

Enrollment

20 participants

Start Date

Oct 1, 2014

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to see how useful the information provided from Positron Emission Tomography (PET) scans can be in the actual planning and delivery of radiation treatment to patients who have head and neck cancers. Patients participating in this study, will have (in addition to their routine tests) a PET scan before and during their radiation treatment. Following the intervention, patients will be followed as per standard practice.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This pilot study is using a combination of PET and CT scans (which show both metabolic activity and detailed anatomy) to better detect and assess head and neck cancers, including how far they have spread, to guide surgical and treatment planning. **You may be eligible if...** - You have been diagnosed with squamous cell carcinoma of the head and neck (a type of cancer affecting the mouth, throat, tongue, voice box, or nearby areas) - You are scheduled for surgery or treatment at the participating center - You are willing to undergo a PET-CT scan as part of your evaluation **You may NOT be eligible if...** - You are pregnant - You have uncontrolled diabetes (which can interfere with PET scan accuracy) - You have had a recent cancer treatment that could distort scan results - You are unable to lie still for the duration of the scan - You have allergies to the scan contrast agents Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUG18-F FDG

All patients enrolled in this study will receive 2 PET Scans: One prior to Radiation, and one during Radiation.


Locations(1)

University Health Network, Princess Margaret Cancer Center

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02678884


Related Trials